Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
3.29M
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
296K
-
Shares change
-
+193K
-
Total reported value, excl. options
-
$1.65M
-
Value change
-
+$1.06M
-
Number of buys
-
13
-
Number of sells
-
-7
-
Price
-
$5.60
Significant Holders of Cellectar Biosciences, Inc. - Common Shares (CLRB) as of Q3 2025
25 filings reported holding CLRB - Cellectar Biosciences, Inc. - Common Shares as of Q3 2025.
Cellectar Biosciences, Inc. - Common Shares (CLRB) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 296K shares
of 3.29M outstanding shares and own 9% of the company stock.
Largest 10 shareholders include Bleichroeder LP (100K shares), VANGUARD GROUP INC (65.2K shares), RENAISSANCE TECHNOLOGIES LLC (24.9K shares), GEODE CAPITAL MANAGEMENT, LLC (24.9K shares), DRW Securities, LLC (21.1K shares), CITADEL ADVISORS LLC (18.5K shares), DIMENSIONAL FUND ADVISORS LP (13K shares), Sequoia Financial Advisors, LLC (10.8K shares), Riverview Capital Advisers, LLC (10.4K shares), and BlackRock, Inc. (4.75K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.